Global Biosimilar of Remicade Market 2023 by Company, Regions, Type and Application, Forecast to 2030

Report ID: IBI1596193 | Category: Service & Software | Pages: 130 | Format: PDF | Published Date: August 16,2023

Request Sample Enquiry before buying Ask For Discount

Single User-$3550.00 Multi User-$4550.00

Report Description
View Table of Contents

Report Summary

The Biosimilar of Remicade market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Biosimilar of Remicade size is estimated to be USD 401620 million in 2030 from USD 307660 million in 2022, with a change XX% between 2022 and 2023. The global Biosimilar of Remicade market size is expected to grow at a CAGR of 6.9% for the next five years.

Market segmentation
Biosimilar of Remicade market is split by Type and by Application. For the period 2018-2030, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
    Monoclonal Antibodies
    Interferon
    Erythropoietin
    Insulin
    Vaccines
    Other

Market segment by Application, can be divided into
    Tumor
    Diabetes
    Cardiovascular
    Hemophilia
    Other

Market segment by players, this report covers
    Roche
    Amgen
    AbbVie
    Sanofi-Aventis
    Johnson & Johnson
    Pfizer
    Novo Nordisk
    Eli Lilly
    Novartis
    Merck
    3sbio
    Changchun High Tech
    CP Guojian
    Biotech
    Gelgen
    Innovent
    Dong Bao
    Ganlee
    United Laboratories

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
    South America (Brazil, Argentina, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Biosimilar of Remicade product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Biosimilar of Remicade, with revenue, gross margin and global market share of Biosimilar of Remicade from 2019 to 2023.
Chapter 3, the Biosimilar of Remicade competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2018-2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2023.and Biosimilar of Remicade market forecast, by regions, type and application, with revenue, from 2023 to 2030.
Chapter 11 and 12, to describe Biosimilar of Remicade research findings and conclusion, appendix and data source.

1 Market Overview
    1.1 Product Overview and Scope of Biosimilar of Remicade
    1.2 Classification of Biosimilar of Remicade by Type
        1.2.1 Overview: Global Biosimilar of Remicade Market Size by Type: 2020 Versus 2021 Versus 2026
        1.2.2 Global Biosimilar of Remicade Revenue Market Share by Type in 2020
        1.2.3 Monoclonal Antibodies
        1.2.4 Interferon
        1.2.5 Erythropoietin
        1.2.6 Insulin
        1.2.7 Vaccines
        1.2.8 Other
    1.3 Global Biosimilar of Remicade Market by Application
        1.3.1 Overview: Global Biosimilar of Remicade Market Size by Application: 2020 Versus 2021 Versus 2026
        1.3.2 Tumor
        1.3.3 Diabetes
        1.3.4 Cardiovascular
        1.3.5 Hemophilia
        1.3.6 Other
    1.4 Global Biosimilar of Remicade Market Size & Forecast
    1.5 Global Biosimilar of Remicade Market Size and Forecast by Region
        1.5.1 Global Biosimilar of Remicade Market Size by Region: 2016 VS 2021 VS 2026
        1.5.2 Global Biosimilar of Remicade Market Size by Region, (2016-2021)
        1.5.3 North America Biosimilar of Remicade Market Size and Prospect (2018-2030)
        1.5.4 Europe Biosimilar of Remicade Market Size and Prospect (2018-2030)
        1.5.5 Asia-Pacific Biosimilar of Remicade Market Size and Prospect (2018-2030)
        1.5.6 South America Biosimilar of Remicade Market Size and Prospect (2018-2030)
        1.5.7 Middle East and Africa Biosimilar of Remicade Market Size and Prospect (2018-2030)
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Biosimilar of Remicade Market Drivers
        1.6.2 Biosimilar of Remicade Market Restraints
        1.6.3 Biosimilar of Remicade Trends Analysis
2 Company Profiles
    2.1 Roche
        2.1.1 Roche Details
        2.1.2 Roche Major Business
        2.1.3 Roche Biosimilar of Remicade Product and Solutions
        2.1.4 Roche Biosimilar of Remicade Revenue, Gross Margin and Market Share (2021-2023)
        2.1.5 Roche Recent Developments and Future Plans
    2.2 Amgen
        2.2.1 Amgen Details
        2.2.2 Amgen Major Business
        2.2.3 Amgen Biosimilar of Remicade Product and Solutions
        2.2.4 Amgen Biosimilar of Remicade Revenue, Gross Margin and Market Share (2021-2023)
        2.2.5 Amgen Recent Developments and Future Plans
    2.3 AbbVie
        2.3.1 AbbVie Details
        2.3.2 AbbVie Major Business
        2.3.3 AbbVie Biosimilar of Remicade Product and Solutions
        2.3.4 AbbVie Biosimilar of Remicade Revenue, Gross Margin and Market Share (2021-2023)
        2.3.5 AbbVie Recent Developments and Future Plans
    2.4 Sanofi-Aventis
        2.4.1 Sanofi-Aventis Details
        2.4.2 Sanofi-Aventis Major Business
        2.4.3 Sanofi-Aventis Biosimilar of Remicade Product and Solutions
        2.4.4 Sanofi-Aventis Biosimilar of Remicade Revenue, Gross Margin and Market Share (2021-2023)
        2.4.5 Sanofi-Aventis Recent Developments and Future Plans
    2.5 Johnson & Johnson
        2.5.1 Johnson & Johnson Details
        2.5.2 Johnson & Johnson Major Business
        2.5.3 Johnson & Johnson Biosimilar of Remicade Product and Solutions
        2.5.4 Johnson & Johnson Biosimilar of Remicade Revenue, Gross Margin and Market Share (2021-2023)
        2.5.5 Johnson & Johnson Recent Developments and Future Plans
    2.6 Pfizer
        2.6.1 Pfizer Details
        2.6.2 Pfizer Major Business
        2.6.3 Pfizer Biosimilar of Remicade Product and Solutions
        2.6.4 Pfizer Biosimilar of Remicade Revenue, Gross Margin and Market Share (2021-2023)
        2.6.5 Pfizer Recent Developments and Future Plans
    2.7 Novo Nordisk
        2.7.1 Novo Nordisk Details
        2.7.2 Novo Nordisk Major Business
        2.7.3 Novo Nordisk Biosimilar of Remicade Product and Solutions
        2.7.4 Novo Nordisk Biosimilar of Remicade Revenue, Gross Margin and Market Share (2021-2023)
        2.7.5 Novo Nordisk Recent Developments and Future Plans
    2.8 Eli Lilly
        2.8.1 Eli Lilly Details
        2.8.2 Eli Lilly Major Business
        2.8.3 Eli Lilly Biosimilar of Remicade Product and Solutions
        2.8.4 Eli Lilly Biosimilar of Remicade Revenue, Gross Margin and Market Share (2021-2023)
        2.8.5 Eli Lilly Recent Developments and Future Plans
    2.9 Novartis
        2.9.1 Novartis Details
        2.9.2 Novartis Major Business
        2.9.3 Novartis Biosimilar of Remicade Product and Solutions
        2.9.4 Novartis Biosimilar of Remicade Revenue, Gross Margin and Market Share (2021-2023)
        2.9.5 Novartis Recent Developments and Future Plans
    2.10 Merck 
        2.10.1 Merck Details
        2.10.2 Merck Major Business
        2.10.3 Merck Biosimilar of Remicade Product and Solutions
        2.10.4 Merck Biosimilar of Remicade Revenue, Gross Margin and Market Share (2021-2023)
        2.10.5 Merck Recent Developments and Future Plans
    2.11 3sbio
        2.11.1 3sbio Details
        2.11.2 3sbio Major Business
        2.11.3 3sbio Biosimilar of Remicade Product and Solutions
        2.11.4 3sbio Biosimilar of Remicade Revenue, Gross Margin and Market Share (2021-2023)
        2.11.5 3sbio Recent Developments and Future Plans
    2.12 Changchun High Tech
        2.12.1 Changchun High Tech Details
        2.12.2 Changchun High Tech Major Business
        2.12.3 Changchun High Tech Biosimilar of Remicade Product and Solutions
        2.12.4 Changchun High Tech Biosimilar of Remicade Revenue, Gross Margin and Market Share (2021-2023)
        2.12.5 Changchun High Tech Recent Developments and Future Plans
    2.13 CP Guojian
        2.13.1 CP Guojian Details
        2.13.2 CP Guojian Major Business
        2.13.3 CP Guojian Biosimilar of Remicade Product and Solutions
        2.13.4 CP Guojian Biosimilar of Remicade Revenue, Gross Margin and Market Share (2021-2023)
        2.13.5 CP Guojian Recent Developments and Future Plans
    2.14 Biotech
        2.14.1 Biotech Details
        2.14.2 Biotech Major Business
        2.14.3 Biotech Biosimilar of Remicade Product and Solutions
        2.14.4 Biotech Biosimilar of Remicade Revenue, Gross Margin and Market Share (2021-2023)
        2.14.5 Biotech Recent Developments and Future Plans
    2.15 Gelgen
        2.15.1 Gelgen Details
        2.15.2 Gelgen Major Business
        2.15.3 Gelgen Biosimilar of Remicade Product and Solutions
        2.15.4 Gelgen Biosimilar of Remicade Revenue, Gross Margin and Market Share (2021-2023)
        2.15.5 Gelgen Recent Developments and Future Plans
    2.16 Innovent
        2.16.1 Innovent Details
        2.16.2 Innovent Major Business
        2.16.3 Innovent Biosimilar of Remicade Product and Solutions
        2.16.4 Innovent Biosimilar of Remicade Revenue, Gross Margin and Market Share (2021-2023)
        2.16.5 Innovent Recent Developments and Future Plans
    2.17 Dong Bao
        2.17.1 Dong Bao Details
        2.17.2 Dong Bao Major Business
        2.17.3 Dong Bao Biosimilar of Remicade Product and Solutions
        2.17.4 Dong Bao Biosimilar of Remicade Revenue, Gross Margin and Market Share (2021-2023)
        2.17.5 Dong Bao Recent Developments and Future Plans
    2.18 Ganlee
        2.18.1 Ganlee Details
        2.18.2 Ganlee Major Business
        2.18.3 Ganlee Biosimilar of Remicade Product and Solutions
        2.18.4 Ganlee Biosimilar of Remicade Revenue, Gross Margin and Market Share (2021-2023)
        2.18.5 Ganlee Recent Developments and Future Plans
    2.19 United Laboratories
        2.19.1 United Laboratories Details
        2.19.2 United Laboratories Major Business
        2.19.3 United Laboratories Biosimilar of Remicade Product and Solutions
        2.19.4 United Laboratories Biosimilar of Remicade Revenue, Gross Margin and Market Share (2021-2023)
        2.19.5 United Laboratories Recent Developments and Future Plans
3 Market Competition, by Players
    3.1 Global Biosimilar of Remicade Revenue and Share by Players (2021-2023)
    3.2 Market Concentration Rate
        3.2.1 Top 3 Biosimilar of Remicade Players Market Share
        3.2.2 Top 10 Biosimilar of Remicade Players Market Share
        3.2.3 Market Competition Trend
    3.3 Biosimilar of Remicade Players Head Office, Products and Services Provided
    3.4 Mergers & Acquisitions
    3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
    4.1 Global Biosimilar of Remicade Revenue and Market Share by Type (2016-2021)
    4.2 Global Biosimilar of Remicade Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
    5.1 Global Biosimilar of Remicade Revenue Market Share by Application (2016-2021)
    5.2 Biosimilar of Remicade Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
    6.1 North America Biosimilar of Remicade Revenue by Type (2018-2030)
    6.2 North America Biosimilar of Remicade Revenue by Application (2018-2030)
    6.3 North America Biosimilar of Remicade Market Size by Country
        6.3.1 North America Biosimilar of Remicade Revenue by Country (2018-2030)
        6.3.2 United States Biosimilar of Remicade Market Size and Forecast (2018-2030)
        6.3.3 Canada Biosimilar of Remicade Market Size and Forecast (2018-2030)
        6.3.4 Mexico Biosimilar of Remicade Market Size and Forecast (2018-2030)
7 Europe by Country, by Type, and by Application
    7.1 Europe Biosimilar of Remicade Revenue by Type (2018-2030)
    7.2 Europe Biosimilar of Remicade Revenue by Application (2018-2030)
    7.3 Europe Biosimilar of Remicade Market Size by Country
        7.3.1 Europe Biosimilar of Remicade Revenue by Country (2018-2030)
        7.3.2 Germany Biosimilar of Remicade Market Size and Forecast (2018-2030)
        7.3.3 France Biosimilar of Remicade Market Size and Forecast (2018-2030)
        7.3.4 United Kingdom Biosimilar of Remicade Market Size and Forecast (2018-2030)
        7.3.5 Russia Biosimilar of Remicade Market Size and Forecast (2018-2030)
        7.3.6 Italy Biosimilar of Remicade Market Size and Forecast (2018-2030)
8 Asia-Pacific by Region, by Type, and by Application
    8.1 Asia-Pacific Biosimilar of Remicade Revenue by Type (2018-2030)
    8.2 Asia-Pacific Biosimilar of Remicade Revenue by Application (2018-2030)
    8.3 Asia-Pacific Biosimilar of Remicade Market Size by Region
        8.3.1 Asia-Pacific Biosimilar of Remicade Revenue by Region (2018-2030)
        8.3.2 China Biosimilar of Remicade Market Size and Forecast (2018-2030)
        8.3.3 Japan Biosimilar of Remicade Market Size and Forecast (2018-2030)
        8.3.4 South Korea Biosimilar of Remicade Market Size and Forecast (2018-2030)
        8.3.5 India Biosimilar of Remicade Market Size and Forecast (2018-2030)
        8.3.6 Southeast Asia Biosimilar of Remicade Market Size and Forecast (2018-2030)
        8.3.7 Australia Biosimilar of Remicade Market Size and Forecast (2018-2030)
9 South America by Country, by Type, and by Application
    9.1 South America Biosimilar of Remicade Revenue by Type (2018-2030)
    9.2 South America Biosimilar of Remicade Revenue by Application (2018-2030)
    9.3 South America Biosimilar of Remicade Market Size by Country
        9.3.1 South America Biosimilar of Remicade Revenue by Country (2018-2030)
        9.3.2 Brazil Biosimilar of Remicade Market Size and Forecast (2018-2030)
        9.3.3 Argentina Biosimilar of Remicade Market Size and Forecast (2018-2030)
10 Middle East & Africa by Country, by Type, and by Application
    10.1 Middle East & Africa Biosimilar of Remicade Revenue by Type (2018-2030)
    10.2 Middle East & Africa Biosimilar of Remicade Revenue by Application (2018-2030)
    10.3 Middle East & Africa Biosimilar of Remicade Market Size by Country
        10.3.1 Middle East & Africa Biosimilar of Remicade Revenue by Country (2018-2030)
        10.3.2 Turkey Biosimilar of Remicade Market Size and Forecast (2018-2030)
        10.3.3 Saudi Arabia Biosimilar of Remicade Market Size and Forecast (2018-2030)
        10.3.4 UAE Biosimilar of Remicade Market Size and Forecast (2018-2030)
11 Research Findings and Conclusion
12 Appendix
    12.1 Methodology
    12.2 Research Process and Data Source
    12.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Global Biosimilar of Remicade Market 2023 by Company, Regions, Type and Application, Forecast to 2030

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?